Compliance and user satisfaction with the intra-uterine contraceptive device in Family Planning Service: The results of a survey in Fife, Scotland, August 2004

European Journal of Contraception and Reproductive Health Care

Volumn 11, Issue 1, 2006, Pages 28-37

  Tewari, Rupa ^a   Kay, Vanessa J ^b  

^a Carnegie Clinic   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Benefits; Compliance; Family planning clinic; Intra uterine contraceptive device; Levonorgestrel releasing intrauterine system

Indexed keywords

COPPER; LEVONORGESTREL;

ADOLESCENT; ADULT; DRUG INDUCED HEADACHE; FAMILY PLANNING; FEMALE; FEMALE SEXUAL DYSFUNCTION; HEALTH SURVEY; HUMAN; INFECTION; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; MOOD DISORDER; NULLIPARA; PAIN; PARITY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SIDE EFFECT; UNITED KINGDOM; VAGINA DISCHARGE; WEIGHT GAIN;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; FAMILY PLANNING SERVICES; FEMALE; HUMANS; INTRAUTERINE DEVICES; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUESTIONNAIRES; SCOTLAND;

EID: 33645326238     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1080/13625180500431422     Document Type: Review

References (28)

1. Forrest JD. Timing of reproductive life stages. Obstet Gynecol 1993;82:105-11.
2. Guillebaud J. Contraception, Your Questions Answered. 2nd edition. London: Churchill Livingston, 1993.
3. World Health Organization (WHO). Medical Eligibility Criteria for Contraceptive Use. Geneva, Switzerland: WHO 2000.
4. Cheng D. The intrauterine device: still misunderstood after all these years. Curr Concepts South Med J 2000;93:859-64.
5. Dawe F, Meltzer H. Contraception and Sexual Health 2002. National Statistics. London: HMSO, 2003; 1-49. www.statistics.gov.uk
6. Luukkainen T, Toivonen J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception 1995;52:269-76.
7. Andersson K, Batar I, Rybo G. Return to fertility after removal of a levonorgestrel releasing intrauterine device and Novo-T. Contraception 1992;46:575-84.
8. Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 micrograms/dl and the copper TCu 380Ag intrauterine contraceptive devices: A multicentred study. International Committee for Contraceptive Research (ICCR). Fertil Steril 1994;61(1):70-7.
9. Gardner FJ, Konje JC, Abrams KR, Brown LJ, Khanna S, Al-Azzawi F, Bell SC, Taylor DJ. Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: A randomized controlled trial. Lancet 2000;356:1698-9.
10. Stewart A, Cummins C, Gold L, Jordan R, Phillips W. The effectiveness of the levonorgestrel-releasing intra-uterine system in menorrhagia: A systematic review. BJOG 2001;108:74-86.
11. Murty J, Barron A, Searle E. Auditing the introduction of a new product to a family planning service. Br J Fam Plann 1998;24:24-5.
12. Sexual Health Strategy Group: Teenage Pregnancy in Fife-update report for 2000-2001, April 2003.
13. Crombie IK, Davies HTO. What shall we do with I.T.? Managing Audit in General Practice 1994;2(4):8-10.
14. Fu H, Darroch JE, Haas T, Ranjit N. Contraceptive failure rates: New estimates from 1995 national survey of family growth. Family Plann Perspect 1999;31(2):56-63.
15. FFPRHC Guidance (January 2004). The copper intrauterine device as long-term contraception. J Fam Plann Reprod Health Care 2004;30(1):29-42.
16. FFPRHC Guidance (April 2004). The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health. J Fam Plann Reprod Health Care 2004;30(2):99-109.
17. Johnson A, Wadsworth J, Wellings K, Field J. The National Survey of Sexual Attitudes and Lifestyles. London: Blackwell Scientific Press, 1994.
18. Cox M, Tripp J, Blacksell S. Clinical performance of the Nova T380 intrauterine device in routine use by the UK family planning and reproductive health research network: 5-year report. J Fam Plann Reprod Health Care 2002;28:69-72.
19. World Health Organization. Mechanism of Action, Safety and Efficacy of Intrauterine Devices - Report of a Scientific Committee, WHO Technical Report Series 753. Geneva: World Health Organization, 1987, p. 16.
20. Luukkainen T. The levonorgestrel-releasing IUD. Br J Fam Plann 1993;19:221-4.
21. Olatinwo AW, Anate M, Balogun OR, Alao MO. Intrauterine contraceptive device (IUD): Sociodemographic characteristics of acceptors, acceptability and effectiveness in a teaching hospital in Nigeria. Niger J Med 2001;10(1):14-7.
22. Neuteboom K, De Kroon CD, Dersjant-Roorda M, Jansen FW. Follow-up visits after IUD-insertion: Sense or nonsense? A technology assessment study to analyze the effectiveness of follow-up visits after IUD insertion. Contraception 2003;68(2):101-4.
23. Brechin S, Gebbie A. Perimenopausal contraception. A faculty aid to continued professional development topic (FACT). Br J Fam Plann 2000:25(1):1-11.
24. French RS, Cowan FM, Mansour DJ, Morris S, Procter T, Hughes D, Robinson A, Guillebaud J. Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systemic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness (Review). Health Technol Assess 2000;4:1-107.
25. Ratsula K, Toivonen J, Lahteenmaki P, Luukkainen T. Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device. Contraception 1989;39:195-204.
26. Barrington JW, Bowen-Simpkins P. The levonorgestrel intrauterine system in the management of menorrhagia. Br J Obstet Gynaecol 1997;104:614-6.
27. Royal College of Obstetrician and Gynaecologist. The Initial Management of Menorrhagia. London: RCOG Press, 1998.
28. Cox M, Tripp J, Blacksell S. Clinical performance of the levonorgestrel intrauterine system in routine use by UK Family Planning and Reproductive Health Research Network: 5 year report. J Fam Plann Reprod Health Care 2002;28:73-7.